Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli.

IF 2.3 4区 医学 Q3 INFECTIOUS DISEASES
Microbial drug resistance Pub Date : 2024-08-01 Epub Date: 2024-06-21 DOI:10.1089/mdr.2024.0026
Fatemeh Alsahlani, Mehri Haeili
{"title":"Genetic Alterations Associated with Colistin Resistance Development in <i>Escherichia coli</i>.","authors":"Fatemeh Alsahlani, Mehri Haeili","doi":"10.1089/mdr.2024.0026","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> The increased incidence of infections due to multidrug-resistant Gram-negative bacteria has led to the renewed interest in the use of 'forgotten' antibiotics such as colistin. In this work, we studied the chromosomal colistin resistance mechanisms among laboratory-induced colistin-resistant <i>Escherichia coli</i> isolates. <b><i>Methods:</i></b> Three colistin-susceptible (ColS) clinical isolates of <i>E. coli</i> assigning to ST131, ST405, and ST361 were exposed to successively increasing concentrations of colistin. The nucleotide sequences of <i>pmrA</i>, <i>pmrB</i>, <i>pmrD</i>, <i>phoP</i>, <i>phoQ</i>, and <i>mgrB</i> genes were determined. The fitness burden associated with colistin resistance acquisition was determined by measuring the <i>in vitro</i> growth rate. <b><i>Results:</i></b> Colistin resistance induction resulted in 16-64 times increase in colistin MICs in mutants (<i>n</i> = 8) compared with parental isolates. Analysis of chromosomal genes in colistin-resistant mutants compared with those of ColS ancestors revealed genetic alterations confined to PmrAB two-component system and included PmrA G53R/R81S/L105P and PmrB E121K/E121A/A159P/A159V/G302E changes. The PmrB E121 was found as a critical position for colistin resistance development being altered in three mutants with different ancestors. The acquired colistin-resistance phenotype was stable following 10 consecutive passages in the absence of selective pressure of colistin and it did not alter the susceptibility of mutants to other antimicrobial agents. All mutants exhibited growth rates similar to their respective ColS ancestors, except for one isolate, which revealed a significant growth defect. <b><i>Conclusion:</i></b> Our results revealed that colistin resistance in <i>E. coli</i> was more related to PmrAB alterations, which did not impose a fitness cost in most cases.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"325-331"},"PeriodicalIF":2.3000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial drug resistance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/mdr.2024.0026","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The increased incidence of infections due to multidrug-resistant Gram-negative bacteria has led to the renewed interest in the use of 'forgotten' antibiotics such as colistin. In this work, we studied the chromosomal colistin resistance mechanisms among laboratory-induced colistin-resistant Escherichia coli isolates. Methods: Three colistin-susceptible (ColS) clinical isolates of E. coli assigning to ST131, ST405, and ST361 were exposed to successively increasing concentrations of colistin. The nucleotide sequences of pmrA, pmrB, pmrD, phoP, phoQ, and mgrB genes were determined. The fitness burden associated with colistin resistance acquisition was determined by measuring the in vitro growth rate. Results: Colistin resistance induction resulted in 16-64 times increase in colistin MICs in mutants (n = 8) compared with parental isolates. Analysis of chromosomal genes in colistin-resistant mutants compared with those of ColS ancestors revealed genetic alterations confined to PmrAB two-component system and included PmrA G53R/R81S/L105P and PmrB E121K/E121A/A159P/A159V/G302E changes. The PmrB E121 was found as a critical position for colistin resistance development being altered in three mutants with different ancestors. The acquired colistin-resistance phenotype was stable following 10 consecutive passages in the absence of selective pressure of colistin and it did not alter the susceptibility of mutants to other antimicrobial agents. All mutants exhibited growth rates similar to their respective ColS ancestors, except for one isolate, which revealed a significant growth defect. Conclusion: Our results revealed that colistin resistance in E. coli was more related to PmrAB alterations, which did not impose a fitness cost in most cases.

与大肠杆菌产生可乐定抗性有关的基因改变
背景:多重耐药革兰氏阴性菌感染的发病率增加,导致人们对使用 "被遗忘 "的抗生素(如可乐定)重新产生了兴趣。在这项工作中,我们研究了实验室诱导的耐秋水仙素大肠埃希菌分离株的染色体秋水仙素耐药机制。研究方法将 ST131、ST405 和 ST361 三种对秋水仙碱敏感(ColS)的临床大肠杆菌分离株暴露于浓度依次增加的秋水仙碱中。测定了 pmrA、pmrB、pmrD、phoP、phoQ 和 mgrB 基因的核苷酸序列。通过测量体外生长速度,确定了与获得可乐定抗性相关的健康负担。结果与亲本分离物相比,秋水仙素耐药性诱导导致突变体(n = 8)的秋水仙素 MICs 增加了 16-64 倍。与 ColS 祖先相比,分析耐秋水仙素突变体的染色体基因发现,基因改变仅限于 PmrAB 双组分系统,包括 PmrA G53R/R81S/L105P 和 PmrB E121K/E121A/A159P/A159V/G302E 变化。在三个不同祖先的突变体中,发现 PmrB E121 是产生可乐定抗性的关键位置。在没有可乐定选择压力的情况下,获得的可乐定抗性表型在连续传代 10 次后保持稳定,而且不会改变突变体对其他抗菌剂的敏感性。所有突变体的生长速度都与各自的 ColS 祖先相似,只有一个分离株显示出明显的生长缺陷。结论我们的研究结果表明,大肠杆菌对可乐定的耐药性与 PmrAB 的改变有很大关系,在大多数情况下,PmrAB 的改变不会导致耐药性的丧失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Microbial drug resistance
Microbial drug resistance 医学-传染病学
CiteScore
6.00
自引率
3.80%
发文量
118
审稿时长
6-12 weeks
期刊介绍: Microbial Drug Resistance (MDR) is an international, peer-reviewed journal that covers the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community. The Journal addresses the serious challenges of trying to decipher the molecular mechanisms of drug resistance. MDR provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports. MDR coverage includes: Molecular biology of resistance mechanisms Virulence genes and disease Molecular epidemiology Drug design Infection control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信